Dr. Lynn Puana Scholarship Opens for 2026–2027 Medical Students
July 16, 2026 — Dr. Lynn Puana Scholarship for Medical Students 2026-2027: Apply now for a one-time award recognizing academic excellence and proactive care. Deadline Jan 15, 2027.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 16, 2026 — Dr. Lynn Puana Scholarship for Medical Students 2026-2027: Apply now for a one-time award recognizing academic excellence and proactive care. Deadline Jan 15, 2027.
July 16, 2026 — Birmingham OB/Gyn announces Trussville Women's Health Center with 3D mammography, ultrasound, and heart health screening. Expanded access for eastern Alabama women.
July 16, 2026 — FleetCollect launches on-demand DOT drug tests for $60 and a random-testing consortium for $8/month, streamlining compliance for owner-operators and small fleets nationwide.
July 16, 2026 — Free Veteran Support Conversation Checklist by Marty Brickey helps family and friends recognize warning signs, start conversations, and connect veterans with PTSD and anxiety resources. Download in 15 minutes.
July 16, 2026 — Dr. Jacqueline Youtsos Scholarship for Medical Students is now accepting applications. $1,000 award for U.S. pre-med and med students. No GPA requirement. Apply by Feb 15, 2027.
July 16, 2026 — NK Family Dental in Bucktown, Chicago, offers holistic dental care with a patient-first philosophy. From cosmetic dentistry to Invisalign, their spa-like facility ensures comfort and convenience. Led by Dr. Nilofer Khan, they provide comprehensive services for all ages.
July 15, 2026 — Kidder Dental expands preventive care in Baton Rouge with exams, cleanings, and sealants as a coordinated framework. Learn how integrated dental services improve long-term oral health.
July 15, 2026 — Darwin AG becomes Novogenia AG, unifying corporate and brand identity to strengthen its international position in personalized healthcare and genetic analysis. Learn how this change impacts investors and customers.
July 15, 2026 — Quantum BioPharma (QNTM) advances LUCID-MS, a potential first-in-class MS therapy targeting myelin repair. Phase 1 safety data supports Phase 2 trial. Read more.
July 15, 2026 — VERAXA Biotech partners with Ardigen to leverage AI for target discovery in its BiTAC(R) oncology platform, aiming to improve cancer therapy development and reduce risks.
July 15, 2026 — SS Innovations International appoints Sarah M. Romano as CFO to lead financial operations and support global expansion, including FDA approval for the SSi Mantra surgical robotic system.
July 15, 2026 — Jett Foundation launches capital campaign for Jett's Place, a wellness and retreat center for Duchenne muscular dystrophy families in Norwell, MA, with $1M gifts from Emilson Family and ITF Therapeutics.
July 15, 2026 — Atlanta lice removal service Lice Happens Atlanta debunks hair dye myth, reaches 10,000 families with non-toxic treatments. Learn why professional removal is effective.
July 15, 2026 — Tonix Pharmaceuticals study in Journal of Virology shows mpox clade IIb is up to 100,000 times less virulent than clade IIa, supporting TNX-801 vaccine development.
July 15, 2026 — Learn proven money-saving tips for dental implants without sacrificing quality. Find affordable options, compare providers, and explore payment plans for a lasting smile.
July 15, 2026 — Nuvectis Pharma (NVCT) prices $100M public offering to fund NXP100, NXP200, and NXP900 pipeline. Learn about the key players and core messages.
July 15, 2026 — Regentis Biomaterials receives European approval for next-gen solvent-free GelrinC manufacturing, boosting yield by 400%. GelrinC is a cell-free hydrogel for cartilage repair targeting a $3B US market. Read more.
July 15, 2026 — NextPlat acquires an independent pharmacy near Pensacola, Florida for $1.5M, expanding its PharmcoRx network into rural markets with same-day delivery and 340B services.
July 15, 2026 — Kairos Pharma reports favorable interim safety for ENV-105 in combination with osimertinib for resistant EGFR-mutated NSCLC. No Grade 3+ adverse events seen in 13 patients.
July 15, 2026 — BioAdaptives launches XcellaraHeart(TM) cardiovascular supplement combining stem cell mobilization with Tanshinone IIA, based on clinical trial showing 268.8% increase in stem cells.